Home › Alzheimer's Disease › Oklahoma
Alzheimer's Disease clinical trials in Oklahoma
6 studies for Alzheimer's Disease are looking for participants at sites in Oklahoma.
Cities in Oklahoma
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1640, Tulsa
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- The Rivus Wellness & Research Institute, Oklahoma City
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Central States Research, Tulsa
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011732Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0089, Ardmore
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984Using Light Therapy for Mild Cognitive Impairment
- University of Oklahoma Health Campus, Oklahoma City
Recruiting
Ages 55 to 95 · All sexes · Updated Jun 16, 2026 · NCT07651787Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Oklahoma City
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.